You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for SERTRALINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for SERTRALINE HYDROCHLORIDE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free S6319_SIGMA ⤷  Get Started Free
NIH Clinical Collection ⤷  Get Started Free SAM001246666 ⤷  Get Started Free
NIH Clinical Collection ⤷  Get Started Free SAM001247100 ⤷  Get Started Free
Hangzhou Trylead Chemical Technology ⤷  Get Started Free TL8005382 ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 63009 ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free S0507 ⤷  Get Started Free
MolPort ⤷  Get Started Free MolPort-003-666-622 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: SERTRALINE HYDROCHLORIDE

Last updated: July 28, 2025

Introduction

Sertraline hydrochloride, a widely prescribed selective serotonin reuptake inhibitor (SSRI), is primarily used for treating depression, anxiety disorders, panic attacks, and obsessive-compulsive disorder. As a cornerstone in mental health therapeutics, the global demand for sertraline has surged, emphasizing the importance of reliable API sourcing. Ensuring high quality, consistent supply, and regulatory compliance remains essential for pharmaceutical manufacturers. This article examines the leading bulk API sources for sertraline hydrochloride, exploring manufacturing regions, key suppliers, supply chain considerations, and quality standards.


Regional Overview of Sertraline API Production

The global API manufacturing landscape for sertraline is predominantly concentrated in large-scale pharmaceutical hubs, notably in Asia, with significant suppliers in India and China. These regions benefit from integrated pharmaceutical ecosystems, offering cost-effective production alongside robust regulatory infrastructure.

  • India: India is a significant player in generic API manufacturing, featuring numerous WHO and ISO-certified facilities. Indian companies such as Aurobindo, Hetero Labs, and Cadila have established comprehensive APIs supply chains for sertraline, leveraging advanced synthesis processes and quality management.

  • China: China hosts a substantial API manufacturing sector, with firms like Zhejiang NHU Company and Zhejiang Jiangsu Hengan Pharmaceutical generating consistent supplies of sertraline API. Chinese manufacturers often cater to both domestic and international markets, complying with stringent GMP standards.

  • Other Regions: Smaller-scale producers in Europe and North America primarily focus on high-value, specialty APIs, often relying on regional manufacturers for bulk sertraline API to meet global demand effectively.


Leading Suppliers of Sertraline Hydrochloride API

  1. Hetero Labs (India): A major supplier with a robust GMP-certified manufacturing plant specializing in SSRIs, including sertraline. Hetero's API quality meets international standards, with a track record of reliable supply.

  2. Aurobindo Pharma (India): Known for its extensive API portfolio, Aurobindo offers high-quality sertraline hydrochloride API, adhering to global regulatory requirements, frequently supplying to multinational pharmaceutical companies.

  3. Zhejiang NHU Company (China): A leading Chinese API manufacturer, NHU supplies sertraline API compatible with international quality standards, serving both domestic and export markets.

  4. Taj Pharmachem (India): Specializes in producing bulk APIs, including sertraline hydrochloride, with a focus on quality assurance and competitive pricing.

  5. Glenmark Pharmaceuticals (India): While predominantly a finished dosage manufacturer, Glenmark also produces API ingredients and supplies sertraline to select partners.

  6. Halcyon Organics (India): A newer entrant with GMP-certified facilities providing competitive sertraline API, emphasizing quality control and supply chain stability.

  7. Sandoz (a division of Novartis, Switzerland): Although primarily known for finished formulations, Sandoz has capabilities for active ingredients, with strategic sourcing from global API manufacturers.


Supply Chain and Regulatory Considerations

  • GMP Certification & Quality Control: Ensuring API suppliers maintain Good Manufacturing Practice (GMP) certification is critical. Certifications from recognized agencies like USFDA, EMA, or WHO are indicators of quality compliance that reduce regulatory risks.

  • Supply Chain Stability: Regional geopolitical stability and trade policies impact the consistency of sertraline API supplies. Indian and Chinese suppliers dominate due to established manufacturing infrastructure, but companies must evaluate import tariffs, customs clearance, and logistical reliability.

  • Regulatory Approvals: Suppliers must comply with stringent regulatory standards, including environmental regulations, safety protocols, and documentation practices. Bi-lateral agreements, such as USFDA approval, can streamline importation for Western markets.


Quality Standards and Certification

Sertraline hydrochloride APIs supplied globally adhere to multiple quality standards:

  • USP, EP, JP, and ICH compliance: These pharmacopoeias define acceptable purity, residual solvent levels, and particle size distribution, crucial for manufacturing efficacy and safety.

  • Batch-to-batch consistency: Leading suppliers implement rigorous quality assurance protocols, including analytical testing for potency, impurity profiling, and stability testing, ensuring raw material reliability.

  • Certification and Documentation: Certificates of Analysis (CoA), Drug Master Files (DMF), and compliance certificates are essential documentation for regulatory submissions and quality audits.


Emerging Trends and Future Outlook

  • Diversification of Suppliers: To mitigate supply chain risks, pharmaceutical manufacturers are increasingly diversifying API sources, engaging both established and emerging suppliers.

  • Advanced Synthesis Techniques: Innovations in green chemistry and process optimization are improving yield, reducing impurities, and lowering costs.

  • Regulatory Harmonization: Increased efforts toward harmonized global standards streamline API registration and approval processes, facilitating wider access for suppliers.

  • Supply Chain Transparency: Digital tracking, blockchain, and real-time monitoring are becoming integral to ensuring API origin authenticity and compliance.


Key Takeaways

  • The primary sources for sertraline hydrochloride API are predominantly located in India and China, with established suppliers like Hetero Labs, Aurobindo Pharma, and Zhejiang NHU ensuring reliable global supply.

  • Rigorous adherence to GMP standards, quality certifications, and regulatory compliance remain non-negotiable for sourcing APIs at scale.

  • Companies should prioritize supply chain diversification, regional geopolitical stability, and emerging manufacturing innovations to safeguard procurement.

  • Continuous quality assurance, transparent documentation, and regulatory diligence are essential for maintaining market access and product integrity.

  • Strategic partnerships with reputable API manufacturers can improve supply reliability, cost-efficiency, and compliance with evolving global standards.


FAQs

1. What are the main regions producing bulk sertraline hydrochloride API?
Primarily India and China dominate global sertraline API manufacturing, leveraging their extensive pharmaceutical industries, regulatory frameworks, and cost advantages. Other regions, including Europe and North America, focus mainly on finishing formulations or niche APIs.

2. How can I verify the quality of sertraline API suppliers?
Verify suppliers’ GMP certification, request Certificates of Analysis, review recent audit reports, and confirm adherence to international pharmacopoeia standards (USP, EP, JP). Engaging with suppliers with approved regulatory filings (e.g., FDA or EMA approvals) further assures quality.

3. Are there risks associated with sourcing from China and India?
While these regions provide cost-effective APIs, risks include regulatory variability, geopolitical tensions, and supply chain disruptions. Due diligence, diversification, and engaging with certified suppliers mitigate these risks.

4. How do emerging synthesis technologies impact sertraline API sourcing?
Innovations in green chemistry and process optimization improve yield, reduce impurities, and lower costs—benefiting both suppliers and buyers. These advances can also simplify compliance and expedite regulatory approvals.

5. What role does regulatory compliance play in API sourcing for sertraline?
Regulatory compliance ensures API quality, safety, and efficacy. Suppliers with recognized certifications and filings facilitate smoother registration processes across markets, reducing delays and legal risks.


References

  1. [1] U.S. Pharmacopeia Convention. USP monograph for Sertraline Hydrochloride.
  2. [2] World Health Organization. WHO GMP guidelines for pharmaceutical manufacturing.
  3. [3] Aurobindo Pharma. Corporate portfolio and regulatory filings.
  4. [4] Zhejiang NHU Company. API manufacturing capabilities and quality assurance.
  5. [5] Hetero Labs. Certification and supply chain information.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.